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ABSTRACT  
Background 
Human ovale malaria is caused by the two closely related species Plasmodium ovale curtisi and P. ovale 
wallikeri. Both species are known to relapse from quiescent hepatic forms months or years after the 
primary infection occurred. Although some studies have succeeded in establishing mosquito transmission 
for ovale malaria, none have specifically described transmission and human hepatocyte infection of both 
sibling species.  
Methods 
Here we describe a simplified protocol for successful transmission of both P. ovale curtisi and P. ovale 
wallikeri to Anopheles coluzzii mosquitoes and streamlined monitoring of infection using sensitive parasite 
DNA detection, by loop-activated amplification, in blood-fed mosquitoes.  
Results 
In one experimental infection with P. ovale curtisi and one with P. ovale wallikeri, viable sporozoites were 
isolated from mosquito salivary glands, and used to successfully infect cultured human hepatocytes.  
Conclusions 
This protocol provides a method for the utilisation of pre-treatment clinical blood samples from ovale 
malaria patients, collected in EDTA, for mosquito infection studies and generation of the hepatic life cycle 
stages of P. ovale curtisi and P. ovale wallikeri. We also demonstrate the utility of LAMP as a rapid and 
sensitive alternative to dissection for estimating the prevalence of infection in Anopheles mosquitoes fed 
with Plasmodium-infected blood.  
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INTRODUCTION 
Plasmodium ovale parasites are a cause of human malaria across tropical regions, including sub-Saharan 
Africa, Asia and islands of the western Pacific (1, 2). It was described as a species in 1922 (1), while the two 
forms  P. ovale curtisi and P. ovale wallikeri, first distinguished in 2010, are now regarded as separate 
species (2, 3). All human Plasmodium parasite infections are initiated by a bite from an infected mosquito, 
injecting sporozoites that invade hepatocytes and form an obligatory liver stage, which develops into 
mature intra-hepatocytic schizonts. In P. vivax, P. o. curtisi and P. o. wallikeri, a proportion of sporozoites 
undergo developmental arrest to form latent liver-stage forms called hypnozoites, which resume hepatic 
development, due to unknown triggers, and cause relapses months or years after the initial infection (4-9). 
The formation of hypnozoites is of public health importance, as these forms are long-lasting reservoirs of 
infection.  
Artemisinin combination therapy (ACT) and other schizonticidal antimalarial drugs can clear blood-stage P. 
ovale spp. infections, but the 8-aminoquinoline primaquine is the only drug currently in use that can kill 
hypnozoites (5). Malaria elimination will depend on the medicines that can kill hypnozoites and therefore 
prevent relapses, however primaquine-based therapy has two major drawbacks (10). Primaquine causes 
haemolysis in G6PD-deficient individuals, and in population pharmacokinetic studies exhibits a short serum 
half-life of 6.7h (11). As such primaquine must be administered for up to 14 days to eliminate hypnozoites, 
and screening populations for G6PD deficiency prior to primaquine administration is usually not feasible 
(12). New drugs are being developed, and studies of the susceptibility of hypnozoites to these new 
compounds require infectious gametocytes for generation of sporozoite-positive mosquitoes, and for 
subsequent hepatic-stage growth in vitro for susceptibility testing. However, as P. ovale spp. cannot be kept 
in continuous culture, due to a requirement for reticulocytes for parasite development (1), gametocytes for 
generation of sporozoites, and later hepatic stages, can only be obtained from human infections. These 
obstacles have prevented much progress in studies of hepatic stages of P. ovale spp. (13).  
The Malaria Reference Laboratory (MRL) at LSHTM receives blood samples from UK cases of imported 
malaria for specialist diagnosis, and surplus diagnostic material is available for further studies [2, 7]. Our 
aim was to develop a protocol using the available EDTA-preserved blood samples from patients infected 
with P. ovale spp. for infective membrane feeds, to produce sporozoites for use in hepatocyte invasion 
assays and subsequently carry out drug susceptibility studies of liver-stage parasites. We describe proof-of-
principle transmission of P. ovale using up to 4 days old EDTA-preserved blood samples, a novel molecular 
strategy for monitoring of mosquito infection status, subsequent penetration of sporozoites into 
hepatocytes and evidence of successful differentiation into exoerythrocytic forms (EEF).  
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MATERIALS AND METHODS 
Plasmodium ovale spp. samples and mosquito infections 
Anonymised, Plasmodium-infected blood samples from the Public Health England Malaria Reference 
Laboratory were obtained for the purpose of developing a work-flow suitable for evaluating liver-stage 
parasite susceptibility to antimalarial drugs. Sodium EDTA-preserved blood samples from gametocytaemic 
patients infected with mono-infections of P. o. curtisi or P. o. wallikeri were mixed 1:1 with fresh blood 
from anonymous donors (blood group O; collected under a LSHTM Research Ethics Committee-approved 
protocol) and used for membrane feeding in pre-warmed calibrated membrane feeders (Hemotek 
Membrane Feeding System, Hemotek Ltd, UK). Female Anopheles coluzzii (N’gousso strain (14)), two to six 
days post-emergence, were used in the experiments and were allowed to feed through an artificial Parafilm 
membrane for 30 minutes.  
Female Anopheles coluzzii (N’gousso strain (14)), two to six days post-emergence, were used in the 
experiments. The mosquitoes were kept in an incubator at 27oC and 70% relative humidity throughout the 
experiment. Mosquitoes were given ad libitum access to 10% glucose/0.05% PABA (para-aminobenzoic 
acid) solution from 24 hours after the feed, so that unfed mosquitoes died and could be removed before 
introduction of glucose solution.   
Daily mosquito mortality was recorded, and dead mosquitoes retained for molecular detection of parasite 
DNA. Surviving mosquitoes were dissected 15-19 days after the infective feed. Prior to dissection, the 
insects were anaesthetised using ethyl acetate and kept on ice. Each mosquito was transferred to a small 
petri dish containing 70% ethanol, and then to another containing RPMI medium. Salivary glands were 
dissected from mosquitoes and kept in RPMI, on ice.  
Sporozoite hepatocyte invasion assay 
Three different hepatocyte lines (Huh7, IHH and HepG2) were tested for optimal sporozoite invasion rates 
by plating out different numbers of cells in Labtek wells (30,000, 20,000 and 10,000), based on previous 
experience in experimental work with hepatic forms of P. berghei. P. falciparum sporozoites were used for 
testing various hepatocyte concentrations (P. falciparum-infected An. stephensi mosquitoes were donated 
to us by colleagues from Imperial College). Cells were incubated for 48, 72, 96 and 144 hours to observe the 
growth of exoerythrocytic forms (EEF).    
P. ovale spp. sporozoites were plated onto the human hepatocyte line Huh7, cultured in RPMI complete 
(RPMI [Gibco] with 10% foetal calf serum [Gibco], 2% L-glutamine [Gibco] and 1% penicillin/streptomycin 
[Gibco] at 37oC with 5% CO2). 24 hours before sporozoite invasion, cells were seeded into Labtek wells 
(ThermoFisher Scientific) at 30,000 cells per well. On the day of infection salivary glands were dissected 
from P. ovale spp.-infected female An. coluzzii mosquitoes. Glands were homogenised and sporozoites 
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isolated by centrifugation. In each experiment, all sporozoite material was added to one well on the Labtek 
slide as sporozoite counts were very low (below 2,000 in total). Slides were centrifuged and incubated for 2 
hours at 37oC with 5% CO2 to permit hepatocyte invasion before being washed 3 times with RPMI 
complete. Slides were incubated for a further 3 to 6 days to allow for EEF development. To stain, cells were 
fixed with 4% paraformaldehyde (PFA) and permeabilised with 0.3% Triton X-100 (Sigma). EEF were stained 
with rabbit antibodies specific to P. falciparum heat shock protein 70 (PfHSP-70) (StressMarq) at 1:50 
dilution, followed by goat anti-rabbit IgG Alexa Fluor 488 fluorescent antibodies (ThermoFisher Scientific) at 
1:5000 dilution. Nuclei were stained with DAPI (ThermoFisher Scientific). Cells were coated in Vectashield 
under a sealed coverslip. Imaging was performed on a Zeiss LSM510 confocal microscope or a Nikon Eclipse 
Ti-E fluorescent microscope. 
Loop-mediated isothermal amplification (LAMP) for detection of parasites in mosquitoes 
DNA was extracted from fed mosquitoes by grinding whole mosquitoes using plastic pestles then boiling in 
0.1mL of 1xTE buffer (10mM Tris-HCl, pH 8.0, 1mM EDTA), followed by phenol/chloroform/isoamyl alcohol 
extraction and 70% ethanol precipitation as described (15). The pan-Plasmodium LAMP kit (Eiken Chemical 
Co., Tokyo, Japan) (16) was used on an Eiken LA-500 turbidimeter, according to manufacturer’s instructions, 
to amplify genus-specific mitochondrial target sequences as confirmation of infection status of all 
mosquitoes. Presence of parasite DNA in mosquitoes at least 5 days post-feed was considered evidence of 
an established P. ovale spp. infection.   
 
RESULTS 
Suitability of different hepatocyte lines 
Multiple cell lines have been used in order to create conditions that promote in vitro hepatocyte invasion 
by malaria parasites, including HepG2 and Huh7 lines for human-infecting Plasmodium species. In 
preliminary experiments, we compared HepG2, Huh7 and the IHH cell line (Kings College, London) using P. 
falciparum sporozoites from NF54-infected mosquitoes. When either IHH or Huh 7 cells were incubated for 
96 hours with P. falciparum sporozoites, EEF were observed developing in host hepatocytes. No EEF were 
observed with HepG2 cells. Parasites in the IHH cells looked rounded while those in the Huh7 cells 
appeared to be larger and better differentiated, an indication of more successful in vitro EEF development 
(data not shown). Seeding of hepatocytes at 30,000 per well was associated with optimal P. falciparum EEF 
invasion and development, hence 30,000 Huh7 cells per well were plated out for P. ovale spp. invasion 
assays.  
Plasmodium ovale spp. transmission experiments 
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Six infective feeding experiments were carried out between April 2016 and March 2017, using anonymised 
P. ovale spp.-infected patient blood (obtained from the Malaria Reference Laboratory, LSHTM) in EDTA. 
Details of parasite density and gametocyte carriage are presented in Table 1.    
Mosquito survival after the infectious feed was monitored. Excluding the non-fed mosquitoes, which all 
died off in the first few days following the feed, 40.4% fed mosquitoes survived following the first feed, 
34.2% the second feed, and 32.9% the third feed (Fig. 1). Survival in different feeds did not vary significantly 
(Log-rank test, p = 0.5928).  
Parasite DNA was detected in mosquitoes from each of the first 3 feeding experiments, but not in 
subsequent experiments (Table 2). A  high proportion of mosquitoes in the group that died within the first 
few days following each feed were positive for parasite DNA by LAMP (Fig. 2). However, this is likely to 
reflect DNA present in the blood meal and not an established viable infection. Parasite DNA was also 
detected in dead mosquitoes 5 days or more post-feed, indicating established infection, in each of the first 
three feeds (Table 2; Fig. 2). Sporozoite DNA was detected in salivary gland material from experiments 1 
and 3, with 10.5% (2/19) and 12% (3/25) of mosquitoes LAMP positive (Fig. 2). Sporozoites were observed 
by microscopy, at low density, in pooled salivary gland homogenates from feeds 1 and 3. Using 
haemocytometer counts, it was estimated that 2000 sporozoites were isolated from feed 1; however 
numbers were too low to accurately estimate sporozoite numbers for feed 3.  
 
Plasmodium ovale spp. hepatocyte invasion assay 
In order to investigate the capacity of the sporozoites to successfully invade hepatocytes, all salivary glands 
dissected from each experiment were pooled and added into a single well seeded with Huh7 cells. After 
incubating 3-6 days to permit initiation of intrahepatic development, EEF were visualised by PfHSP-70 
fluorescence in juxtaposition with DAPI-stained host-cell nuclei. Reflecting the low numbers of sporozoites, 
a single EEF was observed in experiment 1, and 5 EEF in experiment 3 (Fig. 3).   
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DISCUSSION 
These results show that routinely collected EDTA-preserved blood samples from patients with imported 
malaria can be used to successfully infect mosquitoes and produce sporozoites for hepatocyte invasion 
assays, albeit at low densities. This approach is suitable for further development of an extended protocol 
for evaluation of drug susceptibility in the hepatic stages of Plasmodium ovale spp., and other transmission 
studies. Importantly, it should now be possible to perform comparative analyses of the hepatic life cycle 
stages P. ovale curtisi and P. ovale wallikeri , including assessment of the potential for hypnozoite formation 
in these in vitro systems. This is particularly important as the only demonstrable biological difference, to 
date, between these two forms of ovale malaria appears to be contrasting delay times to relapse of 
hypnozoites [7, 17].  
There are several reasons to be cautious before taking strong conclusions from the results we have 
presented. Firstly, the scarcity of material and low efficiency means that repeating and extending the work 
may be difficult. Usable blood samples from UK cases of infection with P. ovale spp. are uncommon; since 
2010 between 66 and 130 ovale malaria cases have been reported to Public Health England (PHE) each year 
(https://www.gov.uk/government/publications/imported-malaria-in-the-uk-statistics; 17), but for only a 
proportion of these are blood samples of sufficient quality for mosquito feeding received by the Malaria 
Reference Laboratory. For the few samples received that were able to be utilised, sporozoite yields from 
infected mosquitoes were poor, leading to low efficiency in the hepatocyte invasion assays. Further, the 
blood samples used are not obtained through planned collection but are sporadically received by the MRL 
from a number of UK facilities, posing a number of challenges (7). The infected blood may be a few days old 
by the time we are able to feed the material to mosquitoes, and may not have been kept under optimum 
conditions for preserving the viability of gametocytes. Further, due to the small sample volume we were 
not able to wash the erythrocytes to remove EDTA, which is the anticoagulant of choice when collecting 
venous blood for preparation of thick and thin films for malaria diagnosis (18).  It is known that the 
presence of EDTA causes some retardation of P. vivax development in mosquitoes, but this inhibition is not 
complete (19).  Reducing EDTA concentration with an equal volume of fresh whole donor blood was used 
as a simple strategy to reduce any inhibition and to help maintain mosquito feeding rates.  
Scaling up will be a challenge with which we will have to deal in the future. The optimum solution would be 
to conduct active sampling specifically for the purpose of membrane feeding the mosquitoes, using heparin 
instead of EDTA as anticoagulant [19]. Infected blood should be maintained at 37°C and fed to mosquitoes 
as soon as possible after collection, to prevent exflagellation and ookinete formation in the tube. Another 
possibility would be to cryopreserve clinical isolates of P. ovale spp. It has been shown that P. vivax 
gametocytes remain stable during the cryopreservation and thawing processes and can be successfully 
used for sporozoite production, which might be an avenue worth exploring for P. ovale spp. as well (20).  
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Apart from increasing the yields it is also important to enhance the longevity of dissected sporozoites, 
which would improve the invasion of hepatocytes and development of EEF. Many different media have 
been used for salivary gland dissection and sporozoite harvesting in the past, and RPMI – as used in these 
three experiments – is a standard medium for such procedures. However, it was recently shown that using 
modified Grace’s insect medium significantly increases viability of P. vivax and P. falciparum sporozoites 
(21). Using compatible vectors and parasites can also determine the success of sporogony. All three 
samples that resulted in infected mosquitoes were of Nigerian origin, and so our protocol matched the 
parasites to a likely compatible vector (An. coluzzii N’gousso strain, originally from Cameroon), which is 
thought to increase prevalence and intensity of infection (20). Mosquito survival following the infective 
feeds was rather low (32.9 – 40.4%), with the highest mortality during the first 5-6 days after the feed. It is 
still not known exactly what effect malaria parasites have on mosquito survival but it is possible that 
parasite-infected mosquitoes incur fitness costs (22). Low survival could also be due to the condition of the 
original blood sample used as a blood meal.  
A number of different in vitro platforms for studies of P. vivax liver stages have been developed (20), but 
very little work on P. ovale spp. liver development has been published. One study found that primary 
cultured human hepatocytes were best able to support in vitro development of P. ovale spp., being 
receptive to sporozoite penetration and permissive for EEF development (22). More recently, humanized 
mice have been successfully used to observe the development of P. ovale liver stages, including 
hypnozoites (24). Our experiments show that the Huh7 line, derived from human cellular carcinoma cells, 
also supports EEF development in P. ovale spp.  
We have demonstrated that P. ovale spp.-infected blood taken directly from patients is able to infect An. 
coluzzi mosquitoes, and that the resultant sporozoites are infective to cultured human hepatocytes. 
Monitoring of mosquito infection status by LAMP proved to be a useful indicator of experimental success. 
Further methodological improvement is now needed to achieve better infection rates and survival of 
mosquitoes, and therefore more efficient invasion of hepatocytes and development of EEF. These studies 
provide an important step towards further study of the development, growth, differentiation and drug 
susceptibility of extra-erythrocytic life cycle stages of P. ovale curtisi and P. ovale wallikeri.   
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Table 1. Overview of the experiments and material used. 
Experiment Parasite species Parasite origin 
Parasite density* 
remarks 
Gametocytes 
present** 
Day of salivary gland 
dissection  
1 P.o. wallikeri Nigeria 78 + 15 days 
2 P.o. wallikeri Nigeria 338 +++ 18 days 
3 P.o. curtisi Nigeria 
48 
mostly late stages 
+++ 19 days 
4 P.o. wallikeri Nigeria 
120 
early stages 
+ 19 days 
5 P.o. wallikeri Not specified 22 + 16 days 
6 P.o. curtisi Nigeria 
28 
late stages only 
+ 15 days 
* All stages P. ovale spp. per 100 leukocytes on Giemsa stained thin blood film 
**  Present: +; Frequent: ++; Abundant: +++  
    
 
 
Table 2. Summary of successful transmission experiments.  
Expt Species 
No. mosquitoes 
offered a blood meal 
No. mosquitoes  
blood-fed 
% LAMP 
positive (n)* 
% established 
infection (n) 
Number. 
dissected 
Number  
LAMP-positive 
Sporozoites 
observed 
1 P.o. wallikeri 70 48 37.5 (18) 16.7 (8) 19 2 YES 
2 P.o. wallikeri 60 38 15.8 (6) 7.9 (3) 13 0 - 
3 P.o. curtisi 100 76 27.6 (21) 7.9 (6) 25 3 YES 
 
*n = number of fed mosquitoes retrieved from day 5 post-feed onwards and tested by LAMP  
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FIGURE LEGENDS 
Figure 1.  Mosquito survival following transmission of P. ovale spp. to An. coluzzii.  
The percent survival of blood-fed mosquitoes after an infective feed is plotted over time (days). 
Starting numbers of mosquitoes in each experiment were 70, 60 and 100, respectively.    
 Poc: P. ovale curtisi;  Pow: P. ovlae wallikeri  
 
Figure 2. Detection of P. ovale spp. DNA in blood-fed An. coluzzii  
For three experimental transmissions conducted with P. o. wallikeri, P. o. wallikeri and P. o. curtisi, 
respectively, dead mosquitoes collected on any day and those surviving to dissection on the days 
indicated were tested for the presence of Plasmodium DNA by LAMP. Salivary glands were 
harvested from surviving mosquitoes on day 15, day 18and day 19 in experiments 1 to 3, 
respectively.      
 
Figure 3.  P. ovale curtisi extra-erythrocytic forms in human hepatocytes   
Sporozoite-exposed HuH7 hepatocytes from experiment 3 were observed by confocal microscopy 
on day 3. Host and parasite DNA (denoting nuclei) was stained with DAPI (blue). P. ovale curtisi 
EEF were immunostained with FITC-conjugated monoclonal anti-P.f HSP70 antibodies (green).  
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